Cannabinoids induce incomplete maturation of cultured human leukemia cells

ABSTRACT Monocyte maturation markers were induced in cultured human myeloblastic ML-2 leukemia cells after treatment for 1-6 days with 0.03-30 microM delta 9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana. After a 2-day or longer treatment,...

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

Alzheimer’s disease (AD) is characterized by enhanced -amyloid peptide (A) deposition along with glial activation in senile plaques, selective neuronal loss, and cognitive deficits. Cannabinoids are neuroprotective agents against excitotoxicity in vitro and...

Cannabinoid System in Neuroprotection, Raphael Mechoulam PhD

[yframe url=’http://www.youtube.com/watch?v=ZI2VT2kOfnM’]

Montel Williams testifies before the Los Angeles City Council: Medical Marijuana and MS

Speaking on behalf of medical marijuana patients everywhere; Montel Williams faces the Los Angeles city council as the vote to regulate dispensaries. Worth mentioning… Montel talks about the effects of butane on people with nervous system disorders – as a...

Stanford Study: Enhancing activity of marijuana-like chemicals in brain helps treat Parkinson's symptoms in mice

STANFORD, Calif. — Marijuana-like chemicals in the brain may point to a treatment for the debilitating condition of Parkinson’s disease. In a study published in the Feb. 8 issue of Nature, researchers from the Stanford University School of Medicine report that...